OCTA is the only non-invasive way for your physician to visualize the vascular structures of your retina.¹ Previously the only way to visualize these blood vessels used fluorescein angiography, a lengthy procedure requiring injections of contrast dye associated with a wide range of side effects and limited imaging results.² With AngioVue, high quality images are available in seconds, without the use of dye injections.
AngioVue is the OCTA technology you can trust: installed in hundreds of clinical sites worldwide and the subject of more scientific studies than any other system.
1. Spaide RF, Klancnik Jr JM, Cooney, MJ. Retinal Vascular Layers Imaged by Fluorescein Angiography and Optical Coherence Tomography Angiography. JAMA Ophthalmol. 2015;133(1):45-50. Published online October 09, 2014.
2. Kwiterovich KA, Maguire MG, Mrphy RP, Schacat AP, Bressler NM, Bressler SB, et al. Frequency of adverse systemic reactions after fluorescein angiography. Results of a prospective study. Ophthalmology. 1991;98:1139-42.
